期刊文献+

立体定向技术注射6-OHDA至内侧前脑束建立帕金森病大鼠模型 被引量:10

PD rat model were established by the injection 6-OHDA into the medial forebrain bundle (MFB) with stereotactic technique
下载PDF
导出
摘要 目的建立大鼠帕金森病模型,观测其行为学和多巴胺能神经元的变化。方法利用立体定向技术,注射6-OHDA至大鼠脑的内侧前脑束,于注射后2、4、6、8周观测阿朴吗啡诱导的大鼠旋转行为学变化;采用免疫组化染色检测TH的表达,了解中脑黑质多巴胺能阳性神经元变化。结果所有大鼠分别于第2、4、6、8周的进行阿朴吗啡诱导旋转行为测试,67只大鼠中出现16只大鼠(23.8%)旋转圈数>7r/min,并且>210r/30min,为合格的PD大鼠模型。第8周时,大鼠旋转次数平均为10.48±1.91/分。免疫组化检测,成功模型光镜下分别计数双侧黑质TH阳性神经元,损毁侧黑质TH阳性神经元占正常侧的3.8%,即毁损侧TH阳性神经元减少96.2%。结论利用立体定向技术,选择内侧前脑束为靶点,可建立6-OHDA大鼠PD模型。 Objective To establish Parkinson's disease rat model and observe the changes of behaviors,nigra dopaminergic neuron of PD rat model. Methods Build up Parkinson's disease model rat by direct injection 6-OHDA into the medial forebrain bundle (MFB) with stereotactic technique. Apomorphine (0. 5mg/kg) injected celiac to evocate circle behavior. The changes of nigra dopaminergic neuron in the model rat were examined with immunohistochemistry. Results 6-OHDA was injected into the medial forebrain bundle brain. A total 66. 7% of the rats rotated over 210 turns per 30 min after 6-OHDA lesions. The immunohistochemical staining showed a significant reduction (in 3.8%) of TH-positive neurons in the 6-OHDA injection side compared with the opposite side. Conclusion PD rat model was successfully established by injection of 6-OHDA with the stereotactic technique.
作者 牛朝诗 李健
出处 《立体定向和功能性神经外科杂志》 2007年第1期19-24,共6页 Chinese Journal of Stereotactic and Functional Neurosurgery
基金 安徽省科技攻关项目(编号:01013030) 安徽省优秀青年科技基金项目(编号:04043072) 安徽省人才开发基金项目(编号:2006Z037)
关键词 立体定向技术 帕金森病 6-羟基多巴胺 大鼠 动物模型 多巴胺能神经元 Stereotactic technique Parkinson's disease 6-Hydroxydopamine Rat Animal model Dopaminegic neuron
  • 相关文献

参考文献25

  • 1牛朝诗,傅先明.帕金森病常用动物模型制作及其进展[J].中华神经医学杂志,2005,4(5):521-524. 被引量:11
  • 2Barneoud P,Parmentier S,Mazadier M,et al.Effects of complete and partial lesions of the dopaminergic mesotelencephalic system on skilled forelimb use in the rat[J].Neuroscience,1995,67(4):837~848.
  • 3Brundin P,Isacson O,Gage FH,et al.The rotating 6-hydroxydopamine-lesioned mouse as a model for assessing functional effects of neuronalgrafting[J].Brain Res,1986,366:346~349.
  • 4Annett LE,Rogers DC,Hernandez TD,et al.Behavioural analysis of unilateral monoamine depletion in the marmoset[J].Brain,1992,115 (Pt 3):825~856.
  • 5Burns RS,Chiueh CC,Markey SP,et al.A primate model of parkinsonism:selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine[J].Proc Natl Acad Sci U S A,1983,80(14):4546~4550.
  • 6Heikkila RE,Hess A,Duvoisin RC.Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice[J].Science,1984,224(4656):1451~1453.
  • 7Johannessen JN,Chiueh CC,Burns RS,et al.Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects[J].Life Sci,1985,36(3):219~224.
  • 8Dabbeni SF,Di SS,Franceschini D,et al.Melatonin protects against 6-OHDA-induced neurotoxicity in rats:a role for mitochondrial complex I activity[J].FASEB J,2001,15(1):164~170.
  • 9Acton PD,Mozley PD.Single photon emission tomography imaging in parkinsonian disorders:a review[J].Behav Neurol,2000,12(1,2):11~27.
  • 10Ungerstedt U.6-Hudroxydopamine induced degeneration of central monoamine neurons[J].Eur J Pharmc,1968,5(1):107~110.

二级参考文献34

  • 1Lapchak PA, Beck KD, Araujo DM, et al. Chronic intranigral administration of brain-derived neurotropic factor produces striatal dopaminergic hypodunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection[J]. Neuroscience, 1993, 53: 639-650.
  • 2Brecknell JE, Dunnett SB, Fawcett JWA. Quantitative study of cell death in the substantia nigra following a mechanical lesion of the medical forebrain bundle [J]. Neuroscience, 1995, 64: 219-227.
  • 3Ben-Shachar Youdim MBH. Intranigral iron injection induces behavioral and biochemical "Parkinsonism" in rats [J]. J Neurochem,1991, 57: 2133-2135.
  • 4Youdim MB, Fridkin M, Zheng H. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases [J]. J Neural Transm, 2004, 111(10-11): 1455-1471.
  • 5Hamaue N, Minami M, Terado M, et al. Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus [J].Neurotoxicology, 2004, 25 ( 1-2): 205 -213.
  • 6Scherzer CR, Jensen RV, Gullans SR,et al. Gene expression changes presage neurodegeneration in a Drosophila model of Parkinson's disease [J]. Hum Mol Genet, 2003, 12(19): 2457-2466.
  • 7Ungerstedt U. 6-Hydroxydopamine induced degeneration of central monoamine neurons [J]. Eur J Pharmcol, 1968, 5(1): 107-110.
  • 8Lee CS, Sauer H, Bjorklund A, et al. Dopaminergic neuronal degeneration and motor impairments following lesions by intrastriatal 6-OHDA in the rat [J] . Neuroscience, 1996, 72(3):641-644.
  • 9Perese DA, Ulman J, Viola J, et al. A 6-hydroxydopamine-induced selective parkinsonian rat model [J]. Brain Res, 1989, 494(2): 285-293.
  • 10Ichitani Y, Okamur H, Nakahara D, et al. Biochemical and immunocytochemical changes induced by intrastriatla dopamine neuron system:evidence for cell death in the substantia migea [J].Exp Neurol, 1994, 130:269-271.

共引文献10

同被引文献99

引证文献10

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部